Decreased cholecystokinin levels in cerebrospinal fluid of patients with adult chronic hydrocephalus syndrome

Biological Psychiatry

Volumn 41, Issue 7, 1997, Pages 804-809

  Galard, Rosa ^a   Poca, Maria Antonia ^a   Catalán, Roberto ^a   Tintoré, Mar ^a   Castellanos, Josep Maria ^a   Sahuquillo, Juan ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Cerebrospinal fluid; Cholecystokinin; Hydrocephalus; Intracranial pressure; Neuropeptides; Normal pressure hydrocephalus

Indexed keywords

CHOLECYSTOKININ; NEUROPEPTIDE;

ADULT; AGED; ARTICLE; BEHAVIOR; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYDROCEPHALUS; MALE; PHYSIOLOGY; PRIORITY JOURNAL;

ADULT; AGED; CHOLECYSTOKININ; CHRONIC DISEASE; FEMALE; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; INTRACRANIAL PRESSURE; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEUROLOGIC EXAMINATION; REFERENCE VALUES; SINCALIDE;

EID: 0030949470     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00098-4     Document Type: Article

References (30)

1. Beinfeld MC, Garver DL (1991): Concentration of cholecystokinin in cerebrospinal fluid is decreased in psychosis: Relationship to symptoms and drug response. Prog Neuropsychopharmacol 15:601-609.
2. Belton NR (1991): Brain damage and raised intracranial pressure - Biochemical and neurophysiological parameters. In Minns RA (ed), Problems of Intracranial Pressure in Childhood, Oxford, New York: MacKeith Press, pp 426-449.
3. Cantor P (1989): Cholecystokinin in plasma. Digestion 42:181-201.
4. Catalan R, Sahuquillo J, Poca MA, Molins A, Castellanos JM, Galard R (1994): Neuropeptide Y cerebrospinal fluid levels in patients with normal pressure hydrocephalus syndrome. Biol Psychiatry 36:61-63.
5. Chawla JC, Hulme A, Cooper R (1974): Intracranial pressure in patients with dementia and communicating hydrocephalus. J Neurosurg 40:376-380.
6. Crawley JN (1991): Cholecystokinin-dopamine interactions. Trends Pharmacol Sci 12:232-236.
7. Crawley JN, Corwin L (1993): Biological Actions of cholecystokinin. Peptides 15:731-755.
8. Galard R, Sanmartí A, Catalan R, Schwartz S, Castellanos JM (1985): Study of different factors affecting arginine-vasopressin radioimmunoassay. Clin Chim Acta 145:119-128.
9. Geracioti TD Jr, Nicholson WE, Orth DN, Ekhator NN, LÑoosen PT (1993): Cholecystokinin in human cerebrospinal fluid: concentrations dynamics, moleculae forms and relationship to fasting and feeding in health, depression and alcoholism. Brain Res 629:260-268.
10. Gerner R, Yamada T (1982): Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Res 238:298-302.
11. Gücer G, Viernstein L, Walker AE (1979): Continuous intracranial pressure recording in adult hydrocephalus. Surg Neurol 13:323-328.
12. Hakim S, Adams RD (1965): The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 2:307-327.
13. Harro J, Vasar E (1991): Cholecystokinin-induced anxiety: How is it reflected in studies on exploratory behavior. Neurosci Biobehav Rev 15:473-477.
14. Katzman R, Hussey F (1970): A simple constant-infusion manometric test for measurement of CSF absorption. Neurology 20:534-543.
15. Lamas E, Lobato RD (1979): Intraventricular pressure and CSF dynamics in chronic adult hydrocephalus. Surg Neurol 12: 287-295.
16. Lindefors N, Lindén A, Brené S, Sedwall G, Persson H (1993): CCK peptides and mRNA in the human brain. Peptides 40:671-690.
17. Lostra F, Verbanck PMP, Gilles C, Mendlewicz J, Vanderhaeghen JJ (1985): Reduced cholecystokinin levels in cerebrospinal fluid of parkinsonian and schizophrenic patients. Ann NY Acad Sci 448:507-517.
18. Lundberg N (1960): Continuous recording and control of ventricular fluid pressure in neurosurgical practice. Acta Psychiat Scand 36:1-53.
19. Lydiard RB, Ballenger JC, Laraia MT, Fossey MD, Beinfeld C (1992): CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects. Am J Psychiatry 149:691-693.
20. Marmarou A, Shulman K, La Morgese J (1975): Compartmental analysis of compliance and outflow resistance of the cerebrospinal fluid system. J Neurosurg 43:523-534.
21. Martinez M, Hernanz A, Gomez Cerezo J, Peña JM, Vazquez JJ, Arnalich F (1993): Alterations in plasma and cerebrospinal fluid levels of neuropeptides in idiopathic senile anorexia. Regul Pept 49:109-117.
22. Molins A, Catalan R, Sahuquillo J, Castellanos JM, Codina A, Galard R (1991): Somatostatin cerebrospinal fluid in dementia. J Neurol 238:168-170.
23. Mutt V, Jorpes E (1966): Structure of porcine cholecystokinin-pancreozymin: I. Cleavage with thrombin and with trypsine. Eur J Biochem 6:156-162.
24. Pickard JD (1984): Normal pressure hydrocephalus - to shunt or not to shunt? In Warlow Ch, Warlow J (eds), Dilemmas in the Management of the Neurological Patient. Edinburgh: Churchill Livingstone, pp 207-214.
25. Raiteri M, Paudice P, Vallebuona F (1993): Release of cholecystokinin in the central nervous system. Neurochem Int 22:519-527.
26. Sahuquillo J, Poca MA, Chasampi A, Ramirez F, Gabas E, Rubio E (1993): Intracranial pressure and cerebrospinal fluid dynamics in the adult chronic hydrocephalus syndrome. In: Avezaat CJJ, van Eijndhoven JHM, Maas AIR, Tans JTJ, eds. Intracranial pressure VIII. Berlin Heidelberg: Springer-Verlag, pp 756-758.
27. Sahuquillo J, Rubio E, Codina A, et al (1991): Reappraisal of the intracranial pressure and cerebrospinal fluid dynamics in patients with the so-called "normal pressure hydrocephalus" syndrome. Acta Neurochir (Wien) 112:50-61.
28. Vanderhaeghen J, Signeau J, Gepts W (1975): New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature 257:604-605.
29. Verbanck PMP, Lostra F, Gilles C, Linkowski P, Mendlewicz J, Vanderhaeghen JJ (1984): Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders. Life Sci 34:67-72.
30. Wooddruff GN, Hughes J (1991): Cholecystokinin antagonists. Annu Rev Pharmacol Toxicol 31:469-501.